IDBS Group

What IDBS Group does

IDBS Group, founded in 1989, is a UK-headquartered (Woking, Surrey) provider of cloud-native laboratory informatics software for multinational biopharmaceutical R&D and manufacturing organizations, operating as a wholly-owned subsidiary of Danaher Corporation. The company's flagship Polar platform unifies Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), and Laboratory Execution System (LES) capabilities in a single architecture, supplemented by E-WorkBook for research, ActivityBase for screening, PIMS/Skyland PIMS for manufacturing process insights, Polar Control for parameter management, Polar Insight for analytics, and an Accelerator Library of pre-built domain workflow apps.

IDBS earns revenue primarily through quote-based enterprise software subscriptions (cloud and on-premise) and professional services, deployed via direct field sales targeting large biopharma, biotech, CDMOs, and CROs, alongside a partner channel of system integrators and technology partners. The company serves 80% of the top 20 global biopharma companies and reports that 15 of those top 20 are 10+ year customers. IDBS maintains a deep GxP and compliance posture (ISO 9001, ISO/IEC 27001 with 27017 expansion, SOC 2 Type 2 with Processing Integrity, 21 CFR Part 11, Qualifyze Platinum Pharma Supplier Status) and operates additional offices in Boston, USA and Singapore.

Strategically, IDBS has shifted toward positioning Polar as a governed, AI-ready data foundation for the biopharma lifecycle, evidenced by integrations with SciBite (ontologies), Synthace (HTPD), Cytiva (UNICORN), AWS, and Alchemi (AI agents for regulatory drafting), plus expansion moves in South Korea. The business is run with a 251–500 headcount under General Manager Pietro Forgione (appointed April 2023), and is not publicly listed.

Name

IDBS Group

Legal name

ID Business Solutions Ltd

Website

https://idbs.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

251–500 employees

Short description

IDBS Group is a Danaher-owned provider of cloud-native lab informatics software (Polar ELN/LIMS/LES platform) for biopharmaceutical R&D and manufacturing, serving 80% of the top 20 global biopharma companies.

Ownership category

akta.pro rank

Product category

Scientific Lab Informatics Software

NAICS

Software Publishers (5132), Computer Systems Design and Related Services (54151)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

Keywords

• Lab informatics software
• Biopharma data management
• Electronic lab notebooks
• Cloud laboratory platform
• GxP compliance solutions

Headquarters

HQ city

Guildford

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Software Licensing and Subscription: IDBS generates revenue primarily through software licensing and subscription fees for its Polar, E-WorkBook, PIMS, and related platforms. The company offers cloud-based SaaS deployment options as well as on-premise installations. Pricing is quote-based and determined by customer requirements, scale, and deployment model.
2. Professional Services: IDBS provides implementation, consulting, and training services to support customer deployments. This includes solutions consulting, professional services, and training & education offerings.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels9 records

Core offering

IDBS Group provides cloud-native scientific enterprise lab informatics software for the biopharmaceutical industry. Its core offering is the Polar platform, which unifies Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), and Laboratory Execution System (LES) capabilities to capture, contextualize, and analyze scientific data across the drug development lifecycle from research through manufacturing. Supporting standalone products include E-WorkBook (ELN), PIMS (manufacturing process insights), ActivityBase (discovery screening), and Skyland PIMS (manufacturing data management).

Product overview

IDBS offers a unified, cloud-native BioPharma Lifecycle Management (BPLM) platform called Polar, which combines ELN (E-WorkBook), LIMS, and LES capabilities to streamline scientific workflows and contextualize data across the full drug development lifecycle from research through commercial manufacturing. The portfolio is structured as a core platform (Polar) with specialized add-on modules including Polar Control (parameter management), Polar Insight (advanced analytics), Polar Bioanalysis (bioanalytical workflows), and an Accelerator Library of pre-built workflow apps. Manufacturing is served by PIMS (acquired via Skyland Analytics/Skyland PIMS), a 21 CFR Part-11 compliant process insights system, while discovery screening is handled by ActivityBase. The products share a common data foundation enabling end-to-end GxP compliance and AI/ML-ready data contextualization.

Differentiator

Problem solved

Functional benefit

Brands

• Polar: Cloud-based BioPharma Lifecycle Management platform combining ELN, LIMS and LES capabilities for research, discovery and development.
• E-WorkBook
• PIMS
• ActivityBase
• Polar Control
• Polar Insight
• Skyland PIMS

Products and services

• Polar Cloud-native unified BioPharma Lifecycle Management platform combining ELN, LIMS and LES capabilities that streamlines scientific workflows, contextualizes experiment, product, and process data, and delivers insights across the biopharma lifecycle from research through manufacturing. Sold to enterprise biopharmaceutical organizations.
• E-WorkBook

Quantifiable outcome

• 30% reduction in study cycle times (BioIVT customer case)
• +9 more outcomes

Named customers21 records

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability8 records

Feature7 records

Partnerships

Nine partnerships are on record, tiered core and secondary.

• AlchemicoreTechnology or Integration · 16 June 2026IDBS and Alchemi partnered to connect AI agents to the IDBS Polar platform for biopharma regulatory filings. The integration allows CMC teams to draft regulatory submissions from governed data while maintaining 21 CFR Part 11 compliance. Alchemi agents can produce regulatory documents up to 70% faster with human-in-the-loop review workflows.
• VantivecoreStrategic or Co-development Partner · 2 December 2025Vantive, a vital organ therapy company specializing in kidney care, selected IDBS's cloud-based Polar platform for enterprise-wide deployment across global operations. The digital transformation initiative replaces legacy on-premise systems with a unified GxP-compliant informatics platform spanning multiple sites in North America, Europe, and Asia.
• CytivasecondaryTechnology or Integration · 1 January 2025Cloud-native integration framework featuring a connector for Cytiva's UNICORN software, enabling integration with Cytiva's bioprocessing equipment and systems.
• SciBitesecondaryTechnology or Integration · 1 March 2023Partnership to bring enterprise ontologies and scientific data management together to unlock value from data through improved interoperability. Addresses FAIR (Findable, Accessible, Interoperable, and Reusable) data principles.
• SynthacesecondaryTechnology or Integration · 7 December 2021Strategic partnership to provide IDBS Polar users with state-of-the-art data foundations for experimentation in high-throughput process development (HTPD). The partnership connects automated biology experimentation with IDBS's scientific data management platform.
• BioPhorumsecondaryStrategic or Co-development Partner · 20 October 2021IDBS joined BioPhorum, a global biopharma collaboration dedicated to accelerating industry progress. IDBS participates in the Information Technology Phorum (BPIT) addressing IT business goals.
• AWSsecondaryTechnology or IntegrationAWS participates in IDBS i3 forums as a strategic technology partner, reinforcing that reliable AI execution depends on structured, contextualized data foundations and governance.
• ElucidatasecondaryTechnology or IntegrationElucidata participates in cross-industry panels at IDBS i3 forums, contributing to discussions on AI-ready data foundations and digital transformation in biopharma.
• TableausecondaryTechnology or IntegrationIDBS and Tableau co-hosted a digitalization best practices seminar attracting leading Korean Biopharma companies, focusing on data visualization and analytics.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Benchling: Cloud-native life sciences R&D platform offering a unified ELN, LIMS, and registry for biopharma; the most direct cloud-native competitor to IDBS's Polar platform among digitally-native biopharma buyers.
• Veeva Systems: Enterprise cloud software for life sciences spanning R&D (Vault) through commercial, including RIM/regulatory and quality — directly competes with IDBS in biopharma data management and CMC/regulatory workflows.
• Dassault Systèmes BIOVIA: Enterprise scientific informatics suite including ELN and discovery-to-manufacturing capabilities; competes with IDBS's E-WorkBook and Polar in large biopharma R&D environments.
• Revvity Signals (formerly PerkinElmer Informatics): Provides Signals Notebook and TiBS workflow platforms for life sciences R&D, directly comparable to IDBS's ELN and lab informatics portfolio across pharma and adjacent life sciences segments.
• LabWare: Specialist in LIMS and ELN for regulated industries including pharma and biobanking; competes with IDBS's LIMS and 21 CFR Part 11 capabilities across QC and manufacturing labs.
• LabVantage Solutions: LIMS-focused vendor with ELN and LES extensions serving pharma, biotech, and CROs/CDMOs; overlaps with IDBS in regulated laboratory informatics and biopharma manufacturing.
• STARLIMS: LIMS and ELN provider with strong presence in clinical, biobanking, and pharma QC labs; competes with IDBS for regulated lab informatics budgets across the biopharma value chain.
• Dotmatics: Scientific R&D platform offering ELN, LIMS, and data analytics for drug discovery and development; competes directly with IDBS in biopharma research informatics workflows.

Emerging players

• Scitara: Lab data integration platform enabling connectivity between instruments, ELN, and LIMS systems; competes with IDBS's integration and platform-connectivity strategy within Polar.

Broad incumbents

• Certara: Biosimulation and regulatory science software for biopharma; overlaps with IDBS in CMC/regulatory content workflows and complements the Polar platform's AI-agentic CMC drafting capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/IDBSsoftware
• YouTubeyoutube.com/user/IDBSsoftware
• LinkedInlinkedin.com/company/idbs

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDBS Group